首页 > 市场调查报告书 > 製药

奈米技术 DDS

市场调查报告书

商品编码

1379062

奈米医学市场：2023-2028 年全球产业趋势、份额、规模、成长、机会与预测

Nanomedicine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日期: 2023年11月02日 | 出版商:

IMARC | 英文 140 Pages | 商品交期: 2-3个工作天内

价格

简介目录图表

抽象的

2022年全球奈米药物市场规模达2,333亿美元。展望未来， IMARC Group预计到2028年市场规模将达到4,883亿美元，2022-2028年复合年增长率（CAGR）为13.1%。

奈米医学是指具有可编程特性的专门多功能药物，用于在分子层面上治疗疾病和修復组织。它涉及使用奈米颗粒、奈米管和奈米装置（例如显影剂、奈米机器人、生物晶片和聚合物疗法）来诊断、治疗和预防疾病，并分析潜在的病理生理学。奈米颗粒包括金属和金属氧化物、脂质体和无机颗粒，用于运输药物并靶向体内难以到达的区域。因此，奈米医学在药物传输、诊断影像、疫苗、再生医学和植入物方面有着广泛的应用。

奈米医学市场趋势：

全球慢性疾病盛行率的不断上升是创造积极市场前景的关键因素之一。奈米医学在治疗肿瘤、神经、泌尿、感染、眼科、骨科、免疫和心血管疾病方面非常有益。与此一致的是，对个人化药物的偏好的转变也促进了市场的成长。此外，用于改进诊断程序的奈米级技术的各种技术进步也起到了其他生长诱导因素的作用。製药商正在使用奈米机器人系统和其他新颖的解决方案来有效管理奈米药物。其他因素，包括医疗保健基础设施的改善，以及生物技术领域的广泛研发（R&D）活动，预计将推动市场成长。

本报告回答的关键问题

全球奈米医药市场有多大？
2023-2028年全球奈米医学市场的预期成长率是多少？
推动全球奈米医学市场的关键因素是什么？
COVID-19 对全球奈米医学市场有何影响？
基于奈米分子类型的全球奈米药物市场的细分情况如何？
基于该产品的全球奈米医学市场的细分情况如何？
基于应用的全球奈米医学市场的细分情况如何？
全球奈米医药市场的重点区域有哪些？
全球奈米医学市场的主要参与者/公司有哪些？

奈米粒子
- 市场走向
- 主要类型
  - 金属和金属氧化物奈米颗粒
  - 脂质体
  - 聚合物和聚合物药物缀合物
  - 水凝胶奈米粒子
  - 树枝状聚合物
  - 无机奈米粒子
- 市场预测
奈米壳
- 市场走向
- 市场预测
奈米管
- 市场走向
- 市场预测
奈米装置
- 市场走向
- 市场预测

第 7 章：按产品分類的市场区隔

疗法
- 市场走向
- 市场预测
再生医学
- 市场走向
- 市场预测
体外诊断
- 市场走向
- 市场预测
体内诊断
- 市场走向
- 市场预测
疫苗
- 市场走向
- 市场预测

第 8 章：按应用分類的市场区隔

临床肿瘤学
- 市场走向
- 市场预测
传染性疾病
- 市场走向
- 市场预测
临床心臟病学
- 市场走向
- 市场预测
骨科
- 市场走向
- 市场预测
其他的
- 市场走向
- 市场预测

第 9 章：按地区分類的市场区隔

北美洲
- 美国
  - 市场走向
  - 市场预测
- 加拿大
  - 市场走向
  - 市场预测
亚太
- 中国
  - 市场走向
  - 市场预测
- 日本
  - 市场走向
  - 市场预测
- 印度
  - 市场走向
  - 市场预测
- 韩国
  - 市场走向
  - 市场预测
- 澳洲
  - 市场走向
  - 市场预测
- 印尼
  - 市场走向
  - 市场预测
- 其他的
  - 市场走向
  - 市场预测
欧洲
- 德国
  - 市场走向
  - 市场预测
- 法国
  - 市场走向
  - 市场预测
- 英国
  - 市场走向
  - 市场预测
- 义大利
  - 市场走向
  - 市场预测
- 西班牙
  - 市场走向
  - 市场预测
- 俄罗斯
  - 市场走向
  - 市场预测
- 其他的
  - 市场走向
  - 市场预测
拉丁美洲
- 巴西
  - 市场走向
  - 市场预测
- 墨西哥
  - 市场走向
  - 市场预测
- 其他的
  - 市场走向
  - 市场预测
中东和非洲
- 市场走向
- 按国家/地区分類的市场细分
- 市场预测

第 10 章：SWOT 分析

概述
优势
弱点
机会
威胁

第 11 章：价值链分析

第 12 章：波特五力分析

概述
买家的议价能力
供应商的议价能力
竞争程度
新进入者的威胁
替代品的威胁

第 13 章：价格分析

第14章：竞争格局

市场结构
关键参与者
关键参与者简介
- Abbott Laboratories
- Arrowhead Pharmaceuticals Inc.
- General Electric Company
- Luminex Corporation
- Merck & Co. Inc.
- Nanobiotix
- Novartis AG
- Pfizer Inc.
- Sanofi SA
- Starpharma Holdings Limited

简介目录图表

Product Code: SR112023A4052

Abstract

The global nanomedicine market size reached US$ 233.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 488.3 Billion by 2028, exhibiting a growth rate (CAGR) of 13.1% during 2022-2028.

Nanomedicine refers to specialized multi-functional drugs with programmable properties used for the treatment of diseases and repairing tissues at a molecular level. It involves the use of nanoparticles, nanotubes and nanodevices, such as imaging agents, nanorobots, biochips and polymer therapeutics, for the diagnosis, treatment and prevention of a disorder and analyzing the underlying pathophysiology. The nanoparticles include metal and metal oxides, liposomes and inorganic particles, which are used for transporting the drugs and targeting difficult to reach areas in the body. As a result, nanomedicine finds extensive applications for drug delivery, diagnostic imaging, vaccines, regenerative medicines and implants.

Nanomedicine Market Trends:

The increasing prevalence of chronic medical ailments across the globe is one of the key factors creating a positive outlook for the market. Nanomedicine is highly beneficial in the treatment of oncological, neurological, urological, infectious, ophthalmological, orthopedic, immunological and cardiovascular diseases. In line with this, shifting preference for personalized medicines is also contributing to the growth of the market. Additionally, various technological advancements in the nanoscale technologies for improved diagnostic procedures are acting as other growth-inducing factors. Pharmaceutical manufacturers are using nanorobotic systems and other novel solutions for the effective administration of nanomedicines. Other factors, including improvements in the healthcare infrastructure, along with extensive research and development (R&D) activities in the field of biotechnology, are anticipated to drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global nanomedicine market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on nanomolecule type, product and application.

Breakup by Nanomolecule Type:

Nanoparticles

Metal and Metal Oxide Nanoparticles

Liposomes

Polymers and Polymer Drug Conjugates

Hydrogel Nanoparticles

Dendrimers

Inorganic Nanoparticles

Nanoshells

Nanotubes

Nanodevices

Breakup by Product:

Therapeutics

Regenerative Medicine

In-Vitro Diagnostics

In-Vivo Diagnostics

Vaccines

Breakup by Application:

Clinical Oncology

Infectious Diseases

Clinical Cardiology

Orthopedics

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Arrowhead Pharmaceuticals Inc., General Electric Company, Luminex Corporation, Merck & Co. Inc., Nanobiotix, Novartis AG, Pfizer Inc., Sanofi SA and Starpharma Holdings Limited.

Key Questions Answered in This Report

1. How big is the global nanomedicine market?
2. What is the expected growth rate of the global nanomedicine market during 2023-2028?
3. What are the key factors driving the global nanomedicine market?
4. What has been the impact of COVID-19 on the global nanomedicine market?
5. What is the breakup of the global nanomedicine market based on the nanomolecule type?
6. What is the breakup of the global nanomedicine market based on the product?
7. What is the breakup of the global nanomedicine market based on the application?
8. What are the key regions in the global nanomedicine market?
9. Who are the key players/companies in the global nanomedicine market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Nanomedicine Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Nanomolecule Type

6.1 Nanoparticles
- 6.1.1 Market Trends
- 6.1.2 Major Types
  - 6.1.2.1 Metal and Metal Oxide Nanoparticles
  - 6.1.2.2 Liposomes
  - 6.1.2.3 Polymers and Polymer Drug Conjugates
  - 6.1.2.4 Hydrogel Nanoparticles
  - 6.1.2.5 Dendrimers
  - 6.1.2.6 Inorganic Nanoparticles
- 6.1.3 Market Forecast
6.2 Nanoshells
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Nanotubes
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
6.4 Nanodevices
- 6.4.1 Market Trends
- 6.4.2 Market Forecast

7 Market Breakup by Product

7.1 Therapeutics
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Regenerative Medicine
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 In-Vitro Diagnostics
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 In-Vivo Diagnostics
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
7.5 Vaccines
- 7.5.1 Market Trends
- 7.5.2 Market Forecast

8 Market Breakup by Application

8.1 Clinical Oncology
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Infectious Diseases
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Clinical Cardiology
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Orthopedics
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
8.5 Others
- 8.5.1 Market Trends
- 8.5.2 Market Forecast

9 Market Breakup by Region

9.1 North America
- 9.1.1 United States
  - 9.1.1.1 Market Trends
  - 9.1.1.2 Market Forecast
- 9.1.2 Canada
  - 9.1.2.1 Market Trends
  - 9.1.2.2 Market Forecast
9.2 Asia-Pacific
- 9.2.1 China
  - 9.2.1.1 Market Trends
  - 9.2.1.2 Market Forecast
- 9.2.2 Japan
  - 9.2.2.1 Market Trends
  - 9.2.2.2 Market Forecast
- 9.2.3 India
  - 9.2.3.1 Market Trends
  - 9.2.3.2 Market Forecast
- 9.2.4 South Korea
  - 9.2.4.1 Market Trends
  - 9.2.4.2 Market Forecast
- 9.2.5 Australia
  - 9.2.5.1 Market Trends
  - 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
  - 9.2.6.1 Market Trends
  - 9.2.6.2 Market Forecast
- 9.2.7 Others
  - 9.2.7.1 Market Trends
  - 9.2.7.2 Market Forecast
9.3 Europe
- 9.3.1 Germany
  - 9.3.1.1 Market Trends
  - 9.3.1.2 Market Forecast
- 9.3.2 France
  - 9.3.2.1 Market Trends
  - 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
  - 9.3.3.1 Market Trends
  - 9.3.3.2 Market Forecast
- 9.3.4 Italy
  - 9.3.4.1 Market Trends
  - 9.3.4.2 Market Forecast
- 9.3.5 Spain
  - 9.3.5.1 Market Trends
  - 9.3.5.2 Market Forecast
- 9.3.6 Russia
  - 9.3.6.1 Market Trends
  - 9.3.6.2 Market Forecast
- 9.3.7 Others
  - 9.3.7.1 Market Trends
  - 9.3.7.2 Market Forecast
9.4 Latin America
- 9.4.1 Brazil
  - 9.4.1.1 Market Trends
  - 9.4.1.2 Market Forecast
- 9.4.2 Mexico
  - 9.4.2.1 Market Trends
  - 9.4.2.2 Market Forecast
- 9.4.3 Others
  - 9.4.3.1 Market Trends
  - 9.4.3.2 Market Forecast
9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast

10 SWOT Analysis

10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
- 14.3.1 Abbott Laboratories
  - 14.3.1.1 Company Overview
  - 14.3.1.2 Product Portfolio
  - 14.3.1.3 Financials
  - 14.3.1.4 SWOT Analysis
- 14.3.2 Arrowhead Pharmaceuticals Inc.
  - 14.3.2.1 Company Overview
  - 14.3.2.2 Product Portfolio
  - 14.3.2.3 Financials
  - 14.3.2.4 SWOT Analysis
- 14.3.3 General Electric Company
  - 14.3.3.1 Company Overview
  - 14.3.3.2 Product Portfolio
  - 14.3.3.3 Financials
- 14.3.4 Luminex Corporation
  - 14.3.4.1 Company Overview
  - 14.3.4.2 Product Portfolio
  - 14.3.4.3 Financials
  - 14.3.4.4 SWOT Analysis
- 14.3.5 Merck & Co. Inc.
  - 14.3.5.1 Company Overview
  - 14.3.5.2 Product Portfolio
  - 14.3.5.3 Financials
  - 14.3.5.4 SWOT Analysis
- 14.3.6 Nanobiotix
  - 14.3.6.1 Company Overview
  - 14.3.6.2 Product Portfolio
  - 14.3.6.3 Financials
- 14.3.7 Novartis AG
  - 14.3.7.1 Company Overview
  - 14.3.7.2 Product Portfolio
  - 14.3.7.3 Financials
  - 14.3.7.4 SWOT Analysis
- 14.3.8 Pfizer Inc.
  - 14.3.8.1 Company Overview
  - 14.3.8.2 Product Portfolio
  - 14.3.8.3 Financials
  - 14.3.8.4 SWOT Analysis
- 14.3.9 Sanofi SA
  - 14.3.9.1 Company Overview
  - 14.3.9.2 Product Portfolio
  - 14.3.9.3 Financials
  - 14.3.9.4 SWOT Analysis
- 14.3.10 Starpharma Holdings Limited
  - 14.3.10.1 Company Overview
  - 14.3.10.2 Product Portfolio
  - 14.3.10.3 Financials

简介目录图表

List of Figures

Figure 1: Global: Nanomedicine Market: Major Drivers and Challenges
Figure 2: Global: Nanomedicine Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Nanomedicine Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Nanomedicine Market: Breakup by Nanomolecule Type (in %), 2022
Figure 5: Global: Nanomedicine Market: Breakup by Product (in %), 2022
Figure 6: Global: Nanomedicine Market: Breakup by Application (in %), 2022
Figure 7: Global: Nanomedicine Market: Breakup by Region (in %), 2022
Figure 8: Global: Nanomedicine (Nanoparticles) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: Nanomedicine (Nanoparticles) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: Nanomedicine (Nanoshells) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Nanomedicine (Nanoshells) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Nanomedicine (Nanotubes) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Nanomedicine (Nanotubes) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Nanomedicine (Nanodevices) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Nanomedicine (Nanodevices) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Nanomedicine (Therapeutics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Nanomedicine (Therapeutics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Nanomedicine (Regenerative Medicine) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Nanomedicine (Regenerative Medicine) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Nanomedicine (In-Vitro Diagnostics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Nanomedicine (In-Vitro Diagnostics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Nanomedicine (In-Vivo Diagnostics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Nanomedicine (In-Vivo Diagnostics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Nanomedicine (Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Nanomedicine (Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Nanomedicine (Clinical Oncology) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Nanomedicine (Clinical Oncology) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Global: Nanomedicine (Infectious Diseases) Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Global: Nanomedicine (Infectious Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: Global: Nanomedicine (Clinical Cardiology) Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: Global: Nanomedicine (Clinical Cardiology) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Global: Nanomedicine (Orthopedics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Global: Nanomedicine (Orthopedics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Global: Nanomedicine (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: Global: Nanomedicine (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: North America: Nanomedicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: North America: Nanomedicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: United States: Nanomedicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: United States: Nanomedicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: Canada: Nanomedicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: Canada: Nanomedicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: Asia-Pacific: Nanomedicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: Asia-Pacific: Nanomedicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: China: Nanomedicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: China: Nanomedicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: Japan: Nanomedicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: Japan: Nanomedicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: India: Nanomedicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: India: Nanomedicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: South Korea: Nanomedicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: South Korea: Nanomedicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: Australia: Nanomedicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: Australia: Nanomedicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: Indonesia: Nanomedicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: Indonesia: Nanomedicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: Others: Nanomedicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: Others: Nanomedicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: Europe: Nanomedicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: Europe: Nanomedicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Germany: Nanomedicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Germany: Nanomedicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: France: Nanomedicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: France: Nanomedicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: United Kingdom: Nanomedicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: United Kingdom: Nanomedicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Italy: Nanomedicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Italy: Nanomedicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Spain: Nanomedicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Spain: Nanomedicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Russia: Nanomedicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Russia: Nanomedicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Others: Nanomedicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Others: Nanomedicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Latin America: Nanomedicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Latin America: Nanomedicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 76: Brazil: Nanomedicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 77: Brazil: Nanomedicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 78: Mexico: Nanomedicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 79: Mexico: Nanomedicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 80: Others: Nanomedicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 81: Others: Nanomedicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 82: Middle East and Africa: Nanomedicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 83: Middle East and Africa: Nanomedicine Market: Breakup by Country (in %), 2022
Figure 84: Middle East and Africa: Nanomedicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 85: Global: Nanomedicine Industry: SWOT Analysis
Figure 86: Global: Nanomedicine Industry: Value Chain Analysis
Figure 87: Global: Nanomedicine Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Nanomedicine Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Nanomedicine Market Forecast: Breakup by Nanomolecule Type (in Million US$), 2023-2028
Table 3: Global: Nanomedicine Market Forecast: Breakup by Product (in Million US$), 2023-2028
Table 4: Global: Nanomedicine Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 5: Global: Nanomedicine Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: Nanomedicine Market: Competitive Structure
Table 7: Global: Nanomedicine Market: Key Players

02-2729-4219

+886-2-2729-4219